About Celagenex
Celagenex is a Healthcare company based in San Ramon (United States) founded in 2019. It develops innovative treatments for diabetes, neurological disorders, and chronic health issues. It operates on a B2B model. The company has 687 employees. Its Indian entity Celagenex Research (India) Private Limited reported revenue of ₹157 Cr. Celagenex offers products and services including Targeted Therapies and Biological Metabolites. Its focus areas include Health, Neurotech, Neurological Disorders and Stroke Recovery. Similar companies include Altimmune, Carmot and BioAge Labs; 3 of its 3 listed similar companies have raised funding.
Company details
Celagenex focuses on developing cutting-edge technologies that combine biological metabolites to manage chronic lifestyle diseases like diabetes and Alzheimers. The company conducts research in neuronal, cardiac, and hepatic health, holding multiple patents for therapies that improve cognition and reduce disease impacts. Based in the US and India, they engage in licensing opportunities and target global health challenges through evidence-based innovations, without direct consumer sales.
- Headquarters San Ramon, United States
- Employees 687
- SectorsHealthcare
- Email••••••••
- Website celagenex.com
- Social LinkedIn Facebook
- Legal Name Celagenex Research (India) Private Limited
- Date of Incorporation 09 Oct, 2019
- Jurisdiction Thane, Maharashtra, India
- Indian entity revenue₹157 Cr
FY 2025 · +53% YoY
- Indian entity net loss-₹9.12 Cr
FY 2025 · -6% margin
- Indian entity EBITDA-₹6.09 Cr
FY 2025 · -4% margin
- Employee Count687
Associated legal entities of Celagenex
Celagenex operates through Celagenex Research (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Celagenex Research (India) Private Limited CIN U36997MH2019PTC331430 | Active | 09 Oct 2019 | Thane, Maharashtra | ₹157 Cr | 687 | 2 | View details |
Products & Services of Celagenex
Celagenex offers a comprehensive portfolio of products and services, including Targeted Therapies and Biological Metabolites.
Therapies for neuronal and cardiac health improvements.
Compounds regulating cellular metabolism for disease management.
Board of directors of Celagenex Research (India) Private Limited (Celagenex)
Celagenex Research (India) Private Limited is the primary company behind Celagenex. The board of Celagenex Research (India) Private Limited currently have 2 directors; the longest-serving is Rajaram Shriram Samant, appointed in 2020. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajaram Shriram Samant DIN 02777466 | Director | 25 Mar 2020 | 6 yrs 7 mo | Celagenex Research (India) Private Limited |
| Dilip Gopal Nevrekar DIN 09728733 | Director | 01 Sep 2022 | 4 yrs 2 mo | Celagenex Research (India) Private Limited |
Financials of Celagenex
Figures of Celagenex Research (India) Private Limited, the primary company behind Celagenex, for FY 2025. Revenue was ₹157 Cr (+53% year on year). Net loss was -₹9.12 Cr (-6% margin). EBITDA was -₹6.09 Cr (-4% margin). Revenue has grown at a compounded annual rate of +79% over three years and +199% over five years.
- ₹157 CrRevenue · FY 2025 · +53% YoY
- -₹9.12 CrNet loss · -6% margin
- -₹6.09 CrEBITDA · -4% margin
- ₹1.8 LakhPaid-up capital
- 687Employees (provident fund records)
- +79%Revenue CAGR, 3 years
- +199%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Celagenex Research (India) Private Limited are on its company page.
Detailed financial statements for Celagenex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Celagenex
Celagenex has 3 listed similar companies in our database, 3 of them funded. They include Altimmune, Carmot and BioAge Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| altimmune.com | 1997 | Gaithersburg, United States | $58M | 17 | Vaccines for infectious diseases and solid tumors are developed. | |
| carmot.us | 2008 | Berkeley, United States | $385.52M | Disease-modifying therapies for metabolic diseases are developed. | ||
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. |
Detailed similar companies of Celagenex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as Celagenex (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celagenex
Celagenex was founded in 2019.
Celagenex is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Celagenex has 687 employees.
The primary company behind Celagenex, Celagenex Research (India) Private Limited, reported revenue of ₹157 Cr for FY 2025, up 53% year on year.
Celagenex focuses on developing cutting-edge technologies that combine biological metabolites to manage chronic lifestyle diseases like diabetes and Alzheimers. The company conducts research in neuronal, cardiac, and hepatic health, holding multiple patents for therapies that improve cognition and reduce disease impacts. Based in the US and India, they engage in licensing opportunities and target global health challenges through evidence-based innovations, without direct consumer sales.
Celagenex's top competitors include BioAge Labs, Carmot and Altimmune.
Celagenex offers Targeted Therapies and Biological Metabolites.
Celagenex operates through Celagenex Research (India) Private Limited.
The legal entities of Celagenex currently have 2 directors, including Dilip Gopal Nevrekar, Rajaram Shriram Samant.